Women & Gender

 {Photo: Sarah McKee/MSH}Youth delegates close out the 4th ICFP in song on January 28, 2016.Photo: Sarah McKee/MSH

A version of this post originally appeared on USAID's Leadership, Management & Governance (LMG) project blog. Nearly 30 staff from Management Sciences for Health (MSH), including several from LMG, participated in the fourth International Conference on Family Planning (ICFP), January 25-28, 2016, in Nusa Dua, Indonesia, which called for "Global Commitments, Local Actions.” The conference was co-hosted by the Bill and Melinda Gates Institute for Population and Reproductive Health at Johns Hopkins Bloomberg School of Public Health and the National Population and Family Planning Board of Indonesia (BKKBN).

 {Photo: Matt Martin/MSH}(from left) Jonathan D. Quick, President & CEO, MSH, moderates the UHC and family planning (FP) access and accountability conversation with panelists: Chris Baryomunsi, Minister of Health, Uganda; Tira Aswitama, National Program Associate for RH and FP, UNFPA Indonesia; Kayode Afolabi, Director Reproductive Health, Federal Ministry of Health, Nigeria; Beth Schlachter, Executive Director, FP2020; John Skibiak, Director, RHSC; Melissa Wanda, Advocacy Officer, MSH Kenya.Photo: Matt Martin/MSH

Post updated February 19, 2016.

Universal Health Coverage (UHC) and universal access to sexual and reproductive health services figure prominently in the Sustainable Development Goals. So it is not surprising that The International Conference on Family Planning (ICFP) maintained important focus on these topics, including through the Management Sciences for Health (MSH) auxiliary event, “Universal Access to Family Planning and Reproductive Health: Who’s Accountable in the Post-2015 Era?” on January 27. Co-sponsored by the Reproductive Health Supplies Coalition (RHSC) and Family Planning 2020 (FP2020), the event featured an illustrious group of panelists giving their perspectives on UHC, while exploring the intersection of health financing policy and accountability as countries move into universal access for family planning.

Jonathan D. Quick, MD, MPH, President and CEO of MSH, moderated the conversation and perhaps stated it best: “Now, more than ever, it is clear that getting family planning into national policies is critical.” 

{Photo: Gwenn Dubourthournieu}Photo: Gwenn Dubourthournieu

For the fourth year in a row, Management Sciences for Health (MSH) invited staff to submit stories about how health systems save lives and improve the health of the poorest and most vulnerable worldwide. MSH staff from 34 projects submitted over 50 stories from 2015. These 12 stories, selected by MSH staff judges, demonstrate how good storytelling and effective partnerships can save more lives.

In this special edition of our Global Health Impact Newsletter (subscribe), meet health workers, community leaders, pharmacy managers, beneficiaries working together toward healthier communities. Stories and authors appear alphabetically by country:

An Accredited Medicines Stores (AMS) seller receives an infrared thermometer to use in Ebola and other outbreak surveillance.

by Arthur Loryoun

Editor's note: This post originally appeared on the Bill & Melinda Gates Foundation's blog, Impatient Optimists. Funded by the Gates Foundation and led by Management Sciences for Health (MSH), the Sustainable Drug Sellers Initiative (SDSI) project worked to ensure the sustainability of public-private drug seller initiatives in Tanzania and Uganda, and to roll-out the initiative in Liberia.

MSH's Douglas Keene, PharmD, MHS, Vice President, Pharmaceuticals & Health Technologies Group, was among the speakers at a recent event in Basel, Switzerland, hosted by Novartis, with representatives from NGOs, academia, and government discussing how to expand access to health in developing countries, including through the newly-launched program, Novartis Access.

MSH is partnering on Novartis Access to help empower governments of low- and lower-middle-income countries to provide access to health for chronic diseases patients who need it most. Ensuring affordable and equitable access to medicines is critical to achieving health for all -- and central to MSH's mission and health-systems strengthening approach.

{Photo Credit: Sara Holtz/MSH}Photo Credit: Sara Holtz/MSH

As the world begins working toward the newly developed Sustainable Development Goals (SDGs), ensuring access to reproductive health supplies must be considered.

More than 100 countries are in the process of adopting or advancing universal health coverage (UHC) mechanisms to achieve the targets set for Goal 3, which calls for “good health and well-being.”

Despite the momentum, 400 million people lack access to at least one of seven life-saving health services. And in 2012, an estimated 222 million women lacked access to effective family planning. FP2020’s goal of enabling 120 million women and girls to use modern contraception requires countries to include sexual and reproductive health services and supplies when discussing health benefits packages under national insurance laws, policies, and other related UHC efforts. Moreover, marginalized populations should be prioritized for free or subsidized care.

{Photo credit: Warren Zelman}Photo credit: Warren Zelman

This blog post is a web-formatted version of the Global Health Impact newsletter: Stronger Health Systems Stop TB and Save Lives (December 2015). (View or share the email version here.) We welcome your feedback and questions in the comments or email us. On social media, use hashtag and tag .  Subscribe

{Photo credit: MSH}Photo credit: MSH

This year, the theme of International Day of Persons with Disabilities is Inclusion matters: access and empowerment for people of all abilities. Far too often, people with disabilities face barriers to inclusion, and are not able to access transportation, employment, education, and other aspects of society.

In a world with a considerable unmet need for appropriate wheelchairs, enormous access challenges for those who do have a wheelchair, a glut of well-intentioned donations of inappropriate wheelchairs languishing in backrooms and landfills, where do you begin to help people who need wheelchairs? Over the last seven years, the World Health Organization (WHO)—with generous support from the US Agency for International Development (USAID)—has established guidelines for appropriate wheelchair provision, developed curricula for wheelchair professionals, and brought together a cadre of passionate supporters for appropriate wheelchair service provision in low resource settings. Training materials are now available, some in many languages including French, Spanish, Portuguese, Turkish, Romanian, Khmer, Thai, and Chinese.

{Photo credit: Warren Zelman}Photo credit: Warren Zelman

This week, at the 46th Union World Conference on Lung Health (hashtag ), the US Agency for International Development (USAID)-funded and Management Sciences for Health (MSH)-led, Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program is launching a new tool to improve how the safety and effectiveness of medicines is monitored in low- and middle-income countries.

All medicines undergo rigorous clinical testing prior to being made publicly available. Continuing to monitor the safety and effectiveness of medicines in real world settings, also referred to as pharmacovigilance, is critically important to ensure that medicines can be used over a prolonged period of time, in conjunction with other medicines, among new patient populations, and in patients with multiple illnesses. 

Low- and middle-income countries, however, often lack the resources, capacity, and systems required to effectively implement pharmacovigilance activities. They often rely heavily on passive reporting methods which can underestimate potential medicines use issues.

Pages

Printer Friendly Version
Subscribe to RSS - Women & Gender